sandrine le noir
UMR7276 Contrôle des réponses immunes B et des lymphoproliférations (CRIBL)
Limoges, France
Review Editor
Vaccines and Molecular Therapeutics
UMR7276 Contrôle des réponses immunes B et des lymphoproliférations (CRIBL)
Limoges, France
Review Editor
Vaccines and Molecular Therapeutics
Seoul National University
Seoul, Republic of Korea
Review Editor
Vaccines and Molecular Therapeutics
National Cancer Institute at Frederick (NIH)
Frederick, United States
Review Editor
Vaccines and Molecular Therapeutics
University of Seoul
Seoul, Republic of Korea
Review Editor
Vaccines and Molecular Therapeutics
Korea University
Seoul, Republic of Korea
Review Editor
Vaccines and Molecular Therapeutics
Department of Emergency Medicine, Taipei Veterans General Hospital
Taipei, Taiwan
Review Editor
Vaccines and Molecular Therapeutics
University of Houston
Houston, United States
Review Editor
Vaccines and Molecular Therapeutics
University of Hawaii at Manoa
Honolulu, United States
Review Editor
Vaccines and Molecular Therapeutics
University of Veterinary Medicine Hannover
Hanover, Germany
Review Editor
Vaccines and Molecular Therapeutics
Emory University
Atlanta, United States
Review Editor
Vaccines and Molecular Therapeutics
National Scientific and Technical Research Council (CONICET)
Buenos Aires, Argentina
Review Editor
Vaccines and Molecular Therapeutics
AuroVaccines
Pearl River, NY, United States
Review Editor
Vaccines and Molecular Therapeutics
National Centre for Foreign Animal Disease, Canadian Food Inspection Agency (CFIA)
Winnipeg, Canada
Review Editor
Vaccines and Molecular Therapeutics
University of California, Riverside
Riverside, United States
Review Editor
Vaccines and Molecular Therapeutics
Australian Respiratory & Sleep Medicine Institute
Adelaide, Australia
Review Editor
Vaccines and Molecular Therapeutics
Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College
Kunming, China
Review Editor
Vaccines and Molecular Therapeutics